Calcium metabolism in sarcoidosis and its clinical implications

被引:81
作者
Conron, M [1 ]
Young, C [1 ]
Beynon, HLC [1 ]
机构
[1] Royal Free Hosp, Dept Med, London NW3 2QG, England
关键词
D O I
10.1093/rheumatology/39.7.707
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To examine the clinical implications of disturbed calcium metabolism in sarcoidosis and how the pathophysiology affects management strategies. Methods. The literature concerning calcium metabolism in sarcoidosis was reviewed. Results. Dysregulated calcium metabolism is a well-recognized complication of sarcoidosis, resulting in hypercalcaemia (prevalence 5-10%), hypercalcuria (40-62%) and reduced bone density (40-55%). Extrarenal synthesis of calcitriol [1,25(OH)(2)D-3] is central to the pathogenesis of abnormal calcium homeostasis, but alterations in parathyroid hormone (PTH) activity and the expression of PTH-related peptide have also been demonstrated. The immunosuppressive properties of calcitriol suggest that the raised levels seen in sarcoidosis could represent an adaptive response to the undefined antigen that causes sarcoidosis. Conclusions. The mechanisms of abnormal calcium metabolism in sarcoidosis need to be understood when treating hypercalcaemia, hypercalcuria and corticosteroid-induced osteoporosis. Studies are required to determine if the currently available therapies for osteoporosis are safe and effective in sarcoidosis.
引用
收藏
页码:707 / 713
页数:7
相关论文
共 80 条
[1]  
Adachi JD, 1996, J RHEUMATOL, V23, P995
[2]   Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis [J].
Adachi, JD ;
Bensen, WG ;
Brown, J ;
Hanley, D ;
Hodsman, A ;
Josse, R ;
Kendler, DL ;
Lentle, B ;
Olszynski, W ;
SteMarie, LG ;
Tenenhouse, A ;
Chines, AA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) :382-387
[3]   VITAMIN-D METABOLITE-MEDIATED HYPERCALCEMIA [J].
ADAMS, JS .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1989, 18 (03) :765-778
[4]   ISOLATION AND STRUCTURAL IDENTIFICATION OF 1,25-DIHYDROXYVITAMIN-D3 PRODUCED BY CULTURED ALVEOLAR MACROPHAGES IN SARCOIDOSIS [J].
ADAMS, JS ;
SINGER, FR ;
GACAD, MA ;
SHARMA, OP ;
HAYES, MJ ;
VOUROS, P ;
HOLICK, MF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (05) :960-966
[5]   CHARACTERIZATION OF 1-ALPHA-HYDROXYLATION OF VITAMIN-D3 STEROLS BY CULTURED ALVEOLAR MACROPHAGES FROM PATIENTS WITH SARCOIDOSIS [J].
ADAMS, JS ;
GACAD, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (04) :755-765
[6]   METABOLISM OF 25-HYDROXYVITAMIN-D3 BY CULTURED PULMONARY ALVEOLAR MACROPHAGES IN SARCOIDOSIS [J].
ADAMS, JS ;
SHARMA, OP ;
GACAD, MA ;
SINGER, FR .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (05) :1856-1860
[7]   POTENTIATION OF THE MACROPHAGE 25-HYDROXYVITAMIN D-1-HYDROXYLATION REACTION BY HUMAN TUBERCULOUS PLEURAL EFFUSION FLUID [J].
ADAMS, JS ;
MODLIN, RL ;
DIZ, MM ;
BARNES, PF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (02) :457-460
[8]   KETOCONAZOLE DECREASES THE SERUM 1,25-DIHYDROXYVITAMIN D AND CALCIUM-CONCENTRATION IN SARCOIDOSIS-ASSOCIATED HYPERCALCEMIA [J].
ADAMS, JS ;
SHARMA, OP ;
DIZ, MM ;
ENDRES, DB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (04) :1090-1095
[9]  
[Anonymous], 1996, Arthritis Rheum, V39, P1791
[10]   HYPERCALCEMIA IN AN ANEPHRIC PATIENT WITH SARCOIDOSIS - EVIDENCE FOR EXTRA-RENAL GENERATION OF 1,25-DIHYDROXYVITAMIN-D [J].
BARBOUR, GL ;
COBURN, JW ;
SLATOPOLSKY, E ;
NORMAN, AW ;
HORST, RL .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (08) :440-443